Analyst Ratings

Date	Action	Analyst	Rating	Target
Apr-09-26	Reiterated	Morgan Stanley	Overweight	$92 → $83
Apr-08-26	Reiterated	UBS	Neutral	$74 → $58
Feb-05-26	Reiterated	BMO Capital		$75 → $78
Jan-20-26	Reiterated	Goldman Sachs	Neutral	$74 → $82
Jan-07-26	Reiterated	Wolfe Research	Underperform	$69 → $66
Jan-07-26	Reiterated	UBS	Neutral	$70 → $74
Dec-17-25	Downgrade	Keefe, Bruyette & Woods	Outperform → Market Perform
Dec-11-25	Reiterated	UBS	Sell	$30 → $70
Oct-30-25	Upgrade	Seaport Global	Neutral → Buy	$81
Oct-08-25	Initiated	Deutsche Bank	Buy	$80

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023
Total Revenue	1,530	1,517	1,195	Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A	720	12	830
Gross Profit	808	1,505	364
Selling, General and Administrative Excl. Other	409	30	108
Research and Development	0	0	0
Other Operating Expense	123	1,201	83
Operating Income	277	274	173
Interest Expense	0	0	0
Unusual Expense	—	—	—
Non-Operating Income (Expense)	-10	-54	0
Net Income Before Taxes	330	327	196
Income Taxes	82	68	45
Consolidated Net Income	221	233	136
Net Income From Continuing Operations	248	260	151
Net Income	221	233	136
EPS (Recurring)	2.94	3.11	1.89
EPS (Basic, Before Extraordinaries)	2.94	3.11	1.89
EPS (Diluted)	2.78	2.94	1.78
EBITDA	299	339	183
Other After Tax Adjustments	—	—	—
Stock Option Compensation Expense	—	—	—
Price To Earnings Ratio	24.17	23.38	—
Price To Sales Ratio	3.29	3.40	—
Gross Margin	52.81	99.21	30.46
Operating Margin	18.10	18.06	14.48
Net Margin	14.44	15.36	11.38
Shares Outstanding	75	75	72
Market Capitalization	5,039	5,156	—
Operating Lease Expense	—	—	—

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cantor Eric	Vice Chairman, MD	Feb 19 '26	Option Exercise	0.00	64,735	0	251,173	Feb 23 12:00 AM
Riehl Nick	Principal Accounting Officer	Feb 19 '26	Option Exercise	0.00	122	0	187	Feb 23 12:00 AM
WATANABE OSAMU R.	General Counsel, Secretary	Feb 19 '26	Option Exercise	0.00	18,438	0	9,350	Feb 23 12:00 AM
WATANABE OSAMU R.	General Counsel, Secretary	Feb 19 '26	Sale	62.23	2,765	172,066	4,981	Feb 23 12:00 AM
Callesano Christopher	Chief Financial Officer	Feb 19 '26	Option Exercise	0.00	4,358	0	3,406	Feb 23 12:00 AM
Pilcher Ciafone Katherine	Chief Operating Officer	Feb 19 '26	Option Exercise	0.00	9,771	0	8,819	Feb 23 12:00 AM
MOELIS KENNETH	Executive Chairman	Feb 18 '26	Option Exercise	0.00	847	0	4,190,479	Feb 20 12:00 AM
Cantor Eric	Vice Chairman, MD	Dec 05 '25	Option Exercise	0.00	1,336	0	219,473	Dec 05 12:00 AM
MOELIS KENNETH	Executive Chairman	Oct 30 '25	Option Exercise	0.00	133,165	0	4,191,326	Nov 03 12:00 AM
Shropshire Kenneth	Director	Aug 22 '25	Sale	72.52	2,615	189,640	7,109	Aug 27 12:00 AM
WATANABE OSAMU R.	General Counsel, Secretary	Jul 25 '25	Sale	72.64	6,340	460,538	131	Jul 29 12:00 AM
MOELIS KENNETH	Chairman, CEO	Mar 07 '25	Option Exercise	0.00	3,750	0	4,324,418	Mar 07 12:00 AM
Shropshire Kenneth	Director	Feb 21 '25	Sale	72.30	2,551	184,437	6,940	Feb 21 12:00 AM
RAICH JEFFREY	Co-President, MD	Feb 19 '25	Option Exercise	0.00	37,516	0	63,517	Feb 21 12:00 AM
Pilcher Ciafone Katherine	Chief Operating Officer	Feb 19 '25	Option Exercise	0.00	14,902	0	7,451	Feb 21 12:00 AM


Market Cap	4.93B	Forward P/E	17.00	EPS next Y	3.95	Insider Trans	0.12%	Shs Float	-	Perf Month	7.92%


Enterprise Value	5.05B	PEG	0.86	EPS next Q	0.64	Inst Own	-	Short Float	-	Perf Quarter	24.50%


Income	218.05M	P/S	3.22	EPS this Y	11.20%	Inst Trans	-	Short Ratio	-	Perf Half Y	-3.16%


Sales	1.53B	P/B	10.27	EPS next Y	27.83%	ROA	17.16%	Short Interest	-	Perf YTD	-2.27%


Book/sh	7.92	P/C	10.81	EPS next 5Y	13.72%	ROE	42.00%	52W High	78.22 -14.11%	Perf Year	19.81%


Cash/sh	1.95	P/FCF	11.83	EPS past 3/5Y	-	ROIC	23.42%	52W Low	51.06 31.57%	Perf 3Y	-


Dividend Est.	2.60 (3.87%)	EV/EBITDA	16.82	Sales past 3/5Y	15.48% 9.98%	Gross Margin	52.86%	Volatility	3.03% 2.83%	Perf 5Y	-


Dividend TTM	2.60 (3.87%)	EV/Sales	3.30	EPS Y/Y TTM	59.55%	Oper. Margin	18.13%	ATR (14)	2.79	Perf 10Y	-


Dividend Ex-Date	May 11, 2026	Quick Ratio	0.70	Sales Y/Y TTM	28.03%	Profit Margin	14.46%	RSI (14)	50.35	Recom	2.71


Dividend Gr. 3/5Y	2.70% -8.94%	Current Ratio	0.70	EPS Q/Q	-21.88%	SMA20	-0.85%	Beta	1.58	Target Price	73.40


Payout	98.81%	Debt/Eq	0.55	Sales Q/Q	4.23%	SMA50	1.20%	Rel Volume	3.06	Prev Close	66.33


Employees	1,308	LT Debt/Eq	0.35	Earnings	Jul 23	SMA200	0.90%	Avg Volume	1.03M	Price	67.18


IPO Date	Apr 16, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.25% -0.62%	Net Debt/EBITDA	0.38	Volume	3,148,943	Change	1.28%

MC